Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)

SHA:688163 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	197.68	194.92	190.13	174.21	207.5	185.45
Other Revenue	-	-	0.02	0.01	1.19	0.11
Revenue	197.68	194.92	190.14	174.22	208.69	185.56
Revenue Growth (YoY)	1.66%	2.51%	9.14%	-16.52%	12.46%	-1.35%
Cost of Revenue	45.28	45.8	49.84	33.5	36.33	35.3
Gross Profit	152.4	149.11	140.3	140.72	172.36	150.27
Selling, General & Admin	77.02	76.71	74.35	73.71	62.81	52.62
Research & Development	19.92	23.84	30.41	15.46	25.76	22.52
Other Operating Expenses	5.22	1.68	1.53	1.21	1.45	-3.25
Operating Expenses	104.31	102.96	107.08	90.28	90.34	71.56
Operating Income	48.08	46.15	33.22	50.45	82.03	78.71
Interest Expense	-0.2	-0.43	-0.65	-0.68	-0.71	-
Interest & Investment Income	4.75	6.12	10.62	16.3	1.48	2.33
Currency Exchange Gain (Loss)	0.07	-0.03	0.12	0.49	-0.12	-
Other Non Operating Income (Expenses)	-0.06	0.23	-0.25	0.42	-0.3	-0.96
EBT Excluding Unusual Items	52.64	52.04	43.06	66.97	82.38	80.09
Gain (Loss) on Sale of Investments	-5.07	-4.97	2.59	2.62	-0.79	-5.34
Gain (Loss) on Sale of Assets	0.45	0.41	-0.01	-0.07	-0.25	-
Other Unusual Items	3.26	3.09	-0.23	4.53	6.54	-
Pretax Income	51.28	50.57	45.42	74.04	87.88	74.75
Income Tax Expense	6.32	6.28	6.64	9.84	11.39	11.58
Earnings From Continuing Operations	44.96	44.29	38.77	64.2	76.48	63.17
Net Income	44.96	44.29	38.77	64.2	76.48	63.17
Net Income to Common	44.96	44.29	38.77	64.2	76.48	63.17
Net Income Growth	1.78%	14.23%	-39.60%	-16.06%	21.07%	-3.93%
Shares Outstanding (Basic)	109	108	108	102	81	81
Shares Outstanding (Diluted)	109	108	108	102	81	81
Shares Change (YoY)	1.31%	0.30%	5.70%	25.24%	0.46%	-0.23%
EPS (Basic)	0.41	0.41	0.36	0.63	0.94	0.78
EPS (Diluted)	0.41	0.41	0.36	0.63	0.94	0.78
EPS Growth	0.47%	13.89%	-42.86%	-32.98%	20.51%	-3.70%
Free Cash Flow	-35.67	-9.12	4.15	41.46	64.68	80.43
Free Cash Flow Per Share	-0.33	-0.08	0.04	0.41	0.80	0.99
Dividend Per Share	0.320	0.320	0.200	0.750	0.900	-
Dividend Growth	-	60.00%	-73.33%	-16.67%	-	-
Gross Margin	77.09%	76.50%	73.79%	80.77%	82.59%	80.98%
Operating Margin	24.32%	23.68%	17.47%	28.96%	39.30%	42.42%
Profit Margin	22.74%	22.72%	20.39%	36.85%	36.65%	34.04%
Free Cash Flow Margin	-18.05%	-4.68%	2.18%	23.79%	30.99%	43.34%
EBITDA	66.3	65.5	49.46	64.43	96.15	-
EBITDA Margin	33.54%	33.61%	26.01%	36.98%	46.07%	-
D&A For EBITDA	18.22	19.36	16.24	13.98	14.12	-
EBIT	48.08	46.15	33.22	50.45	82.03	78.71
EBIT Margin	24.32%	23.68%	17.47%	28.96%	39.30%	42.42%
Effective Tax Rate	12.32%	12.41%	14.62%	13.29%	12.97%	15.49%
Revenue as Reported	197.68	194.92	190.14	174.22	208.69	185.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.